AUPP279698A0
(en)
*
|
1998-04-03 |
1998-04-30 |
Sunscape Developments Limited |
Sustained release formulation
|
DE10026698A1
(de)
|
2000-05-30 |
2001-12-06 |
Basf Ag |
Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
|
US6733783B2
(en)
*
|
2000-10-30 |
2004-05-11 |
Euro-Celtique S.A. |
Controlled release hydrocodone formulations
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
US11207805B2
(en)
|
2001-10-12 |
2021-12-28 |
Aquestive Therapeutics, Inc. |
Process for manufacturing a resulting pharmaceutical film
|
US7666337B2
(en)
|
2002-04-11 |
2010-02-23 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
US10285910B2
(en)
|
2001-10-12 |
2019-05-14 |
Aquestive Therapeutics, Inc. |
Sublingual and buccal film compositions
|
US8603514B2
(en)
|
2002-04-11 |
2013-12-10 |
Monosol Rx, Llc |
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|
US20190328679A1
(en)
|
2001-10-12 |
2019-10-31 |
Aquestive Therapeutics, Inc. |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
US8900497B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for making a film having a substantially uniform distribution of components
|
US20110033542A1
(en)
|
2009-08-07 |
2011-02-10 |
Monosol Rx, Llc |
Sublingual and buccal film compositions
|
US20070281003A1
(en)
|
2001-10-12 |
2007-12-06 |
Fuisz Richard C |
Polymer-Based Films and Drug Delivery Systems Made Therefrom
|
US8900498B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for manufacturing a resulting multi-layer pharmaceutical film
|
US8765167B2
(en)
|
2001-10-12 |
2014-07-01 |
Monosol Rx, Llc |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
US7357891B2
(en)
|
2001-10-12 |
2008-04-15 |
Monosol Rx, Llc |
Process for making an ingestible film
|
US8017150B2
(en)
|
2002-04-11 |
2011-09-13 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
DE10224607B4
(de)
*
|
2002-06-04 |
2008-03-13 |
Lts Lohmann Therapie-Systeme Ag |
Filmförmige, zerfallsfähige Zubereitungen zur Wirkstofffreisetzung und Verfahren zu deren Herstellung
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
US7442387B2
(en)
*
|
2003-03-06 |
2008-10-28 |
Astellas Pharma Inc. |
Pharmaceutical composition for controlled release of active substances and manufacturing method thereof
|
ATE495732T1
(de)
|
2003-03-26 |
2011-02-15 |
Egalet As |
Morphin-system mit kontrollierter freisetzung
|
DE102004032051A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
DE10361596A1
(de)
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
NZ545202A
(en)
*
|
2003-08-06 |
2010-03-26 |
Gruenenthal Chemie |
Abuse-proofed dosage form comprising opiods and a high molecular weight polyethylene oxide
|
DE102005005446A1
(de)
*
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
US8377952B2
(en)
|
2003-08-28 |
2013-02-19 |
Abbott Laboratories |
Solid pharmaceutical dosage formulation
|
US8025899B2
(en)
|
2003-08-28 |
2011-09-27 |
Abbott Laboratories |
Solid pharmaceutical dosage form
|
US7201920B2
(en)
|
2003-11-26 |
2007-04-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of opioid containing dosage forms
|
KR101199608B1
(ko)
|
2004-03-30 |
2012-11-08 |
리립사, 인크. |
이온 불균형 치료를 위한 방법 및 조성물
|
US20050238721A1
(en)
*
|
2004-04-07 |
2005-10-27 |
Acquarulo Lawrence A Jr |
One step compounding extrusion of drug filled polymers
|
US20050255157A1
(en)
*
|
2004-05-11 |
2005-11-17 |
Glenmark Pharmaceuticals Limited |
Sustained release, mucoadhesive vaginal pharmaceutical compositions
|
LT1765292T
(lt)
|
2004-06-12 |
2018-01-10 |
Collegium Pharmaceutical, Inc. |
Nuo piktnaudžiavimo apsaugotos vaistų formos
|
DE102004032049A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
DE102004032103A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
JP5259183B2
(ja)
†
|
2004-07-01 |
2013-08-07 |
グリューネンタール・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
乱用に対して保護された経口剤形
|
US20080152595A1
(en)
*
|
2004-11-24 |
2008-06-26 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
US20060147518A1
(en)
*
|
2004-12-30 |
2006-07-06 |
Pierre Fabre Medicament |
Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
WO2007068615A2
(en)
*
|
2005-12-14 |
2007-06-21 |
F. Hoffmann-La Roche Ag |
Hcv prodrug formulation
|
CN101360483B
(zh)
*
|
2006-01-19 |
2012-10-31 |
陶氏环球技术有限责任公司 |
含有乙基纤维素的生物活性组合物
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
BRPI0715635A2
(pt)
*
|
2006-09-01 |
2013-07-02 |
Teva Pharma |
compàsitos sàlidos de um composto de cÁlcio receptor-ativo
|
DE102007011485A1
(de)
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
WO2008148798A2
(en)
|
2007-06-04 |
2008-12-11 |
Egalet A/S |
Controlled release pharmaceutical compositions for prolonged effect
|
KR20100067655A
(ko)
*
|
2007-08-28 |
2010-06-21 |
다우 글로벌 테크놀로지스 인크. |
세정 용도를 위한 캡슐화된 활성 성분
|
TWI454288B
(zh)
|
2008-01-25 |
2014-10-01 |
Gruenenthal Chemie |
藥物劑型
|
EP2262484B1
(de)
|
2008-03-11 |
2013-01-23 |
Depomed, Inc. |
Gastroretentive darreichungsformen mit verzögerter freisetzung mit komibinationen aus einem nichtopioiden analgetikum und einem opioiden analgetikum
|
US8372432B2
(en)
|
2008-03-11 |
2013-02-12 |
Depomed, Inc. |
Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
|
PT2273983T
(pt)
|
2008-05-09 |
2016-10-28 |
Gruenenthal Gmbh |
Processo para a preparação de uma formulação em pó intermediária e uma forma de dosagem sólida final sob utilização de uma etapa de congelamento por atomização
|
WO2010022193A2
(en)
*
|
2008-08-20 |
2010-02-25 |
Board Of Regents, The University Of Texas System |
Hot-melt extrusion of modified release multi-particulates
|
TWI478712B
(zh)
|
2008-09-30 |
2015-04-01 |
Astellas Pharma Inc |
釋控性醫藥組成物
|
EP2393484A1
(de)
|
2009-02-06 |
2011-12-14 |
Egalet Ltd. |
Gegen missbrauch durch alkoholeinnahme widerstandsfähige zusammensetzung mit unmittelbarer freisetzung
|
CA2766179A1
(en)
|
2009-06-24 |
2010-12-29 |
Egalet Ltd. |
Controlled release formulations
|
KR101747156B1
(ko)
|
2009-07-22 |
2017-06-27 |
그뤼넨탈 게엠베하 |
산화-안정화된 탬퍼-내성 용량형
|
RU2547555C2
(ru)
|
2009-07-22 |
2015-04-10 |
Грюненталь Гмбх |
Экструдированная из горячего расплава фармацевтическая лекарственная форма
|
EP3064064A1
(de)
*
|
2009-09-30 |
2016-09-07 |
Acura Pharmaceuticals, Inc. |
Verfahren und zusammensetzungen zur abschreckung vor missbrauch
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
US8597681B2
(en)
|
2009-12-22 |
2013-12-03 |
Mallinckrodt Llc |
Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
|
US9198861B2
(en)
|
2009-12-22 |
2015-12-01 |
Mallinckrodt Llc |
Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
|
ES2606227T3
(es)
|
2010-02-03 |
2017-03-23 |
Grünenthal GmbH |
Preparación de una composición farmacéutica en polvo mediante una extrusora
|
PL2554168T3
(pl)
|
2010-03-29 |
2018-05-30 |
Astellas Pharma Inc. |
Kompozycja farmaceutyczna do kontrolowanego uwalniania
|
EP2611425B1
(de)
|
2010-09-02 |
2014-07-02 |
Grünenthal GmbH |
Manipulationssichere darreichungsform mit einem anionischen polymer
|
EP2611426B1
(de)
|
2010-09-02 |
2014-06-25 |
Grünenthal GmbH |
Manipulationssichere darreichungsform mit einem anorganischen salz
|
US9149959B2
(en)
|
2010-10-22 |
2015-10-06 |
Monosol Rx, Llc |
Manufacturing of small film strips
|
WO2012061779A1
(en)
|
2010-11-04 |
2012-05-10 |
Abbott Gmbh & Co. Kg |
Drug formulations
|
WO2012061780A1
(en)
|
2010-11-04 |
2012-05-10 |
Abbott Gmbh & Co. Kg |
Method for producing monolithic tablets
|
PT2826467T
(pt)
|
2010-12-22 |
2017-10-25 |
Purdue Pharma Lp |
Formas envolvidas de dosamento de libertação controlada resistentes à adulteração
|
CA2822769C
(en)
|
2010-12-23 |
2016-10-04 |
Purdue Pharma L.P. |
Tamper resistant solid oral dosage forms
|
HUE030921T2
(en)
|
2011-04-29 |
2017-06-28 |
Moberg Pharma Ab |
Pharmaceutical preparations containing a local anesthetic such as bupivacaine for topical administration to the mouth or throat
|
US9050335B1
(en)
|
2011-05-17 |
2015-06-09 |
Mallinckrodt Llc |
Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia
|
US8741885B1
(en)
|
2011-05-17 |
2014-06-03 |
Mallinckrodt Llc |
Gastric retentive extended release pharmaceutical compositions
|
US8858963B1
(en)
|
2011-05-17 |
2014-10-14 |
Mallinckrodt Llc |
Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
|
US20130028972A1
(en)
|
2011-07-29 |
2013-01-31 |
Grunenthal Gmbh |
Tamper-resistant tablet providing immediate drug release
|
DK2736495T3
(da)
|
2011-07-29 |
2017-11-13 |
Gruenenthal Gmbh |
Misbrugsbestandig tablet som tilvejebringer øjeblikkelig frigivelse af lægemiddel
|
CA2864949A1
(en)
|
2012-02-28 |
2013-09-06 |
Grunenthal Gmbh |
Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
|
EA201401139A1
(ru)
|
2012-04-18 |
2015-03-31 |
Грюненталь Гмбх |
Устойчивая к разрушению и к сбросу дозы фармацевтическая лекарственная форма
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
CA2877774C
(en)
|
2012-07-12 |
2017-07-18 |
Mallinckrodt Llc |
Extended release, abuse deterrent pharmaceutical compositions
|
US10702453B2
(en)
|
2012-11-14 |
2020-07-07 |
Xerox Corporation |
Method and system for printing personalized medication
|
ES2691982T3
(es)
|
2012-11-30 |
2018-11-29 |
Acura Pharmaceuticals, Inc. |
Liberación autorregulada de un principio activo farmacéutico
|
KR101659983B1
(ko)
|
2012-12-31 |
2016-09-26 |
주식회사 삼양바이오팜 |
용융 압출된 방출 제어용 약학 조성물, 및 이를 포함하는 경구용 제제
|
SG11201506064UA
(en)
|
2013-02-05 |
2015-08-28 |
Purdue Pharma Lp |
Tamper resistant pharmaceutical formulations
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
JP6466417B2
(ja)
|
2013-05-29 |
2019-02-06 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
二峰性放出プロファイルを有する改変防止(tamper−resistant)剤形
|
MX371432B
(es)
|
2013-05-29 |
2020-01-30 |
Gruenenthal Gmbh |
Forma de dosificacion resistente al uso indebido que contiene una o mas particulas.
|
KR20160031526A
(ko)
|
2013-07-12 |
2016-03-22 |
그뤼넨탈 게엠베하 |
에틸렌-비닐 아세테이트 중합체를 함유하는 템퍼 내성 투여형
|
US10195153B2
(en)
|
2013-08-12 |
2019-02-05 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded immediate release abuse deterrent pill
|
CN105934241B
(zh)
|
2013-11-26 |
2020-06-05 |
格吕伦塔尔有限公司 |
通过低温研磨制备粉末状药物组合物
|
CA2934078C
(en)
*
|
2013-12-17 |
2019-08-06 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded extended release abuse deterrent pill
|
WO2015095391A1
(en)
|
2013-12-17 |
2015-06-25 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded extended release abuse deterrent pill
|
US9492444B2
(en)
|
2013-12-17 |
2016-11-15 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded extended release abuse deterrent pill
|
WO2015120201A1
(en)
|
2014-02-05 |
2015-08-13 |
Kashiv Pharma, Llc |
Abuse-resistant drug formulations with built-in overdose protection
|
WO2015145461A1
(en)
|
2014-03-26 |
2015-10-01 |
Sun Pharma Advanced Research Company Ltd. |
Abuse deterrent immediate release biphasic matrix solid dosage form
|
EP3142646A1
(de)
|
2014-05-12 |
2017-03-22 |
Grünenthal GmbH |
Manipulationssichere kapselformulierung mit tapentadol mit unmittelbarer freisetzung
|
MX2016015417A
(es)
|
2014-05-26 |
2017-02-22 |
Gruenenthal Gmbh |
Multiparticulas protegidas contra vertido de dosis etanolico.
|
CA2955229C
(en)
|
2014-07-17 |
2020-03-10 |
Pharmaceutical Manufacturing Research Services, Inc. |
Immediate release abuse deterrent liquid fill dosage form
|
US9132096B1
(en)
|
2014-09-12 |
2015-09-15 |
Alkermes Pharma Ireland Limited |
Abuse resistant pharmaceutical compositions
|
AU2015317358A1
(en)
*
|
2014-09-19 |
2017-04-27 |
Board Of Regents, The University Of Texas System |
Methods of preparing extrudates
|
CA2964628A1
(en)
|
2014-10-20 |
2016-04-28 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extended release abuse deterrent liquid fill dosage form
|
EP3285745A1
(de)
|
2015-04-24 |
2018-02-28 |
Grünenthal GmbH |
Manipulationssichere darreichungsform mit sofortiger freisetzung und widerstand gegen lösungsmittelextraktion
|
US9956172B2
(en)
|
2015-07-28 |
2018-05-01 |
Board Of Regents, The University Of Texas System |
Implant compositions for the unidirectional delivery of therapeutic compounds to the brain
|
WO2017040607A1
(en)
|
2015-08-31 |
2017-03-09 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for self-regulated release of active pharmaceutical ingredient
|
JP2018526414A
(ja)
|
2015-09-10 |
2018-09-13 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
|
US9943513B1
(en)
|
2015-10-07 |
2018-04-17 |
Banner Life Sciences Llc |
Opioid abuse deterrent dosage forms
|
MX2018008868A
(es)
|
2016-02-08 |
2018-09-21 |
SpecGx LLC |
Composiciones farmaceuticas que contienen glucomanano con liberacion extendida y propiedades disuasivas de abuso.
|
JP7023859B2
(ja)
|
2016-03-31 |
2022-02-22 |
スペックジーエックス エルエルシー |
徐放性乱用防止剤形
|
US10335405B1
(en)
|
2016-05-04 |
2019-07-02 |
Patheon Softgels, Inc. |
Non-burst releasing pharmaceutical composition
|
US11273131B2
(en)
|
2016-05-05 |
2022-03-15 |
Aquestive Therapeutics, Inc. |
Pharmaceutical compositions with enhanced permeation
|
JP2019519487A
(ja)
|
2016-05-05 |
2019-07-11 |
アクエスティブ セラピューティクス インコーポレイテッド |
送達増強エピネフリン組成物
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
EP3269361A1
(de)
|
2016-07-14 |
2018-01-17 |
Omya International AG |
Darreichungsform
|
US10335375B2
(en)
|
2017-05-30 |
2019-07-02 |
Patheon Softgels, Inc. |
Anti-overingestion abuse deterrent compositions
|
US20200206139A1
(en)
*
|
2017-09-11 |
2020-07-02 |
Board Of Regents, The University Of Texas System |
Compositions for the improved delivery of drugs
|